273 related articles for article (PubMed ID: 30883079)
21. Targeting glioma stem cells enhances anti-tumor effect of boron neutron capture therapy.
Sun T; Li Y; Huang Y; Zhang Z; Yang W; Du Z; Zhou Y
Oncotarget; 2016 Jul; 7(28):43095-43108. PubMed ID: 27191269
[TBL] [Abstract][Full Text] [Related]
22. The acceleration of boron neutron capture therapy using multi-linked mercaptoundecahydrododecaborate (BSH) fused cell-penetrating peptide.
Michiue H; Sakurai Y; Kondo N; Kitamatsu M; Bin F; Nakajima K; Hirota Y; Kawabata S; Nishiki T; Ohmori I; Tomizawa K; Miyatake S; Ono K; Matsui H
Biomaterials; 2014 Mar; 35(10):3396-405. PubMed ID: 24452095
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption.
Hsieh CH; Chen YF; Chen FD; Hwang JJ; Chen JC; Liu RS; Kai JJ; Chang CW; Wang HE
J Nucl Med; 2005 Nov; 46(11):1858-65. PubMed ID: 16269600
[TBL] [Abstract][Full Text] [Related]
24. Folate-conjugated gene-carrying microbubbles with focused ultrasound for concurrent blood-brain barrier opening and local gene delivery.
Fan CH; Chang EL; Ting CY; Lin YC; Liao EC; Huang CY; Chang YC; Chan HL; Wei KC; Yeh CK
Biomaterials; 2016 Nov; 106():46-57. PubMed ID: 27544926
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of prognostic integrin α2β1 PET tracer and concurrent targeting delivery using focused ultrasound for brain glioma detection.
Chung YH; Hsu PH; Huang CW; Hsieh WC; Huang FT; Chang WC; Chiu H; Hsu ST; Yen TC
Mol Pharm; 2014 Nov; 11(11):3904-14. PubMed ID: 25153169
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics and boron uptake of BSH (Na2B12H11SH) in patients with intracranial tumors.
Kageji T; Nakagawa Y; Kitamura K; Matsumoto K; Hatanaka H
J Neurooncol; 1997 May; 33(1-2):117-30. PubMed ID: 9151229
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of a Novel Boron-Containing α-D-Mannopyranoside for BNCT.
Tsurubuchi T; Shirakawa M; Kurosawa W; Matsumoto K; Ubagai R; Umishio H; Suga Y; Yamazaki J; Arakawa A; Maruyama Y; Seki T; Shibui Y; Yoshida F; Zaboronok A; Suzuki M; Sakurai Y; Tanaka H; Nakai K; Ishikawa E; Matsumura A
Cells; 2020 May; 9(5):. PubMed ID: 32455737
[TBL] [Abstract][Full Text] [Related]
28. Use of boron cluster-containing redox nanoparticles with ROS scavenging ability in boron neutron capture therapy to achieve high therapeutic efficiency and low adverse effects.
Gao Z; Horiguchi Y; Nakai K; Matsumura A; Suzuki M; Ono K; Nagasaki Y
Biomaterials; 2016 Oct; 104():201-12. PubMed ID: 27467416
[TBL] [Abstract][Full Text] [Related]
29. Combination of the vascular targeting agent ZD6126 with boron neutron capture therapy.
Masunaga S; Sakurai Y; Suzuki M; Nagata K; Maruhashi A; Kinash Y; Ono K
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):920-7. PubMed ID: 15465210
[TBL] [Abstract][Full Text] [Related]
30. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
Chou FI; Chung HP; Liu HM; Chi CW; Lui WY
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330
[TBL] [Abstract][Full Text] [Related]
31. In vivo investigation of boron-rich nanodrugs for treating triple-negative breast cancers via boron neutron capture therapy.
Lan KW; Huang WY; Chiu YL; Hsu FT; Chien YC; Hsiau YY; Wang TW; Keng PY
Biomater Adv; 2023 Dec; 155():213699. PubMed ID: 37979440
[TBL] [Abstract][Full Text] [Related]
32. Covalent Organic Polymer as a Carborane Carrier for Imaging-Facilitated Boron Neutron Capture Therapy.
Shi Y; Fu Q; Li J; Liu H; Zhang Z; Liu T; Liu Z
ACS Appl Mater Interfaces; 2020 Dec; 12(50):55564-55573. PubMed ID: 33327054
[TBL] [Abstract][Full Text] [Related]
33. Boron neutron capture therapy for glioblastoma.
Yamamoto T; Nakai K; Matsumura A
Cancer Lett; 2008 Apr; 262(2):143-52. PubMed ID: 18313207
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetic study of BSH and BPA in simultaneous use for BNCT.
Yokoyama K; Miyatake S; Kajimoto Y; Kawabata S; Doi A; Yoshida T; Asano T; Kirihata M; Ono K; Kuroiwa T
J Neurooncol; 2006 Jul; 78(3):227-32. PubMed ID: 16557351
[TBL] [Abstract][Full Text] [Related]
35. PET pharmacokinetic analysis to estimate boron concentration in tumor and brain as a guide to plan BNCT for malignant cerebral glioma.
Nariai T; Ishiwata K; Kimura Y; Inaji M; Momose T; Yamamoto T; Matsumura A; Ishii K; Ohno K
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S348-50. PubMed ID: 19375930
[TBL] [Abstract][Full Text] [Related]
36. Manipulation of Mitophagy by "All-in-One" nanosensitizer augments sonodynamic glioma therapy.
Qu F; Wang P; Zhang K; Shi Y; Li Y; Li C; Lu J; Liu Q; Wang X
Autophagy; 2020 Aug; 16(8):1413-1435. PubMed ID: 31674265
[TBL] [Abstract][Full Text] [Related]
37. Boron neutron capture therapy for glioblastoma multiforme: enhanced drug delivery and antitumor effect following blood-brain barrier disruption induced by focused ultrasound.
Yang FY; Chen YW; Chou FI; Yen SH; Lin YL; Wong TT
Future Oncol; 2012 Oct; 8(10):1361-9. PubMed ID: 23130933
[TBL] [Abstract][Full Text] [Related]
38. In vitro and in vivo evaluation of carboranyl uridines as boron delivery agents for neutron capture therapy.
Liu L; Barth RF; Tjarks W; Soloway AH; Anisuzzaman AK
Anticancer Res; 1996; 16(1):113-20. PubMed ID: 8615595
[TBL] [Abstract][Full Text] [Related]
39. Applicability of the 2-nitroimidazole-sodium borocaptate-10B conjugate, TX-2060, as a 10B-carrier in boron neutron capture therapy.
Masunaga S; Nagasawa H; Hiraoka M; Sakurai Y; Uto Y; Hori H; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Ono K
Anticancer Res; 2004; 24(5A):2975-83. PubMed ID: 15517904
[TBL] [Abstract][Full Text] [Related]
40. Boron neutron capture therapy of cancer: current status and future prospects.
Barth RF; Coderre JA; Vicente MG; Blue TE
Clin Cancer Res; 2005 Jun; 11(11):3987-4002. PubMed ID: 15930333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
